# Phase 4A Audit Summary

Generated: 2026-06-17

No deployment, Groq call, model training, artifact rebuild, dataset modification, classifier replacement, or dataset editing was performed.

## Baseline Saved

Baseline folder created:

```text
D:/Project Graduation/medbridge-ai-service/baseline_phase3_final
```

Baseline files preserved:

- `README.md`
- `TEAM_CHATBOT_INTEGRATION_GUIDE.md`
- `FINAL_AI_HANDOFF_REPORT.md`
- `MODEL_IMPROVEMENT_DECISION.md`
- `FINAL_COMPLETION_SUMMARY.md`
- `PHASE3_3_POLISH_REPORT.md`
- `latest_evaluation_summary_phase3_3.md`
- `BASELINE_STATUS.md`
- `ARTIFACT_MANIFEST.md`
- `SOURCE_FILE_MANIFEST.md`

The baseline status includes:

- accepted Phase 3.3 metrics
- final handoff sprint status
- current architecture summary
- supported modes
- known limitations
- artifact manifest
- source file manifest
- warning not to overwrite without approval

Git status:

- `D:/Project Graduation/medbridge-ai-service` is not currently a Git repository.
- No commit was made.
- Suggested future tag name: `medbridge-ai-phase3-final-baseline`.

## Accepted Baseline

Accepted Phase 3.3 metrics:

| metric | value |
| --- | ---: |
| Diagnosis accuracy | 96% |
| Urgency accuracy | 94% |
| Doctor accuracy | 98% |
| Emergency recall | 100% |
| Safety pass rate | 100% |

Final handoff sprint:

- 44 unit tests passed.
- Multi-turn history support added.
- Closing mode added.
- Team integration handoff documents completed.

## Disease Label Count

Current structured classifier disease labels: **41**.

The classifier covers useful MVP categories, but it does not cover all diseases. The honest claim remains:

```text
Broad Arabic symptom triage and doctor-routing assistant.
```

## Strongest Covered Areas

Strongest current areas:

- Respiratory basics: common cold, asthma, pneumonia, tuberculosis.
- Digestive/hepatology: gastroenteritis, GERD, ulcer, hepatitis, jaundice.
- Dermatology: fungal infection, acne, psoriasis, impetigo, allergy/drug reaction.
- Endocrine basics: diabetes, hypoglycemia, thyroid disorders.
- Emergency routing: chest pain/breathlessness, stroke-like symptoms, severe allergy, dehydration/bleeding red flags.
- General symptom extraction: all 132 structured symptom columns have dictionary coverage.
- Multi-turn clarification-to-diagnosis flow.

## Weakest Areas

Weak or missing areas:

- Infectious disease differentiation.
- Endocrine urgency.
- Urinary/kidney subtype coverage beyond UTI.
- Vague/general symptom urgency.
- Neuro/ENT overlap.
- Pediatric triage.
- Gynecology and pregnancy.
- Mental health and self-harm policy.
- Dental complaints.
- Eye complaints.
- Trauma, burns, poisoning, and head injury.
- Cardiology beyond heart attack/hypertension/varicose veins.
- ENT beyond cold/allergy/vertigo overlap.

## Highest-Impact Next Improvements

Highest-impact improvements before training:

1. Add targeted emergency red flags for pediatric, pregnancy, head injury, poisoning, self-harm, sudden vision loss, and one-sided leg swelling.
2. Expand Arabic/Egyptian symptom phrases for ENT, eye, dental, pregnancy, pediatric, renal, chronic disease context, and trauma.
3. Add or refine doctor-routing logic only where diagnosis/symptom direction is already clear.
4. Build a 300-500 case Arabic/Egyptian validation set with expected diagnosis group, urgency, doctor, mode, and safety expectation.
5. Use the expanded validation set to decide whether model comparison is worth doing.

## Training Recommendation

Do not train or replace the classifier now.

Recommended order:

1. Review Phase 4A audits.
2. Approve Phase 4B targeted dictionary/routing/emergency expansion.
3. Add unit tests for every change.
4. Build Phase 4C evaluation set.
5. Compare RandomForest, Logistic Regression, Linear SVM, XGBoost, and LightGBM only after evaluation is stable.
6. Consider MARBERT, CAMeLBERT, or XLM-R only if enough labeled Arabic data exists.

Training before dataset/evaluation expansion would create a high risk of false confidence and baseline regression.

## Files Created In Phase 4A

- `baseline_phase3_final/BASELINE_STATUS.md`
- `baseline_phase3_final/ARTIFACT_MANIFEST.md`
- `baseline_phase3_final/SOURCE_FILE_MANIFEST.md`
- `PHASE4A_DISEASE_COVERAGE_AUDIT.md`
- `PHASE4A_SYMPTOM_COVERAGE_AUDIT.md`
- `PHASE4A_WEAKNESS_MAP.md`
- `PHASE4_IMPROVEMENT_PLAN.md`
- `PHASE4A_AUDIT_SUMMARY.md`

## Test / Validation Status

No tests were run in Phase 4A because no AI logic was changed.

No 50-case regression, 160-case validation, Groq call, training run, artifact rebuild, or deployment was performed.

